Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Inkwood Research | PRODUCT CODE: 1142630

Cover Image

PUBLISHER: Inkwood Research | PRODUCT CODE: 1142630

North America Epilepsy Devices Market Forecast 2022-2030

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 1600
PDF & Excel (Corporate License)
USD 2200

Add to Cart

KEY FINDINGS

The North America epilepsy devices market is predicted to increase with an 8.01% CAGR by the end of the forecast period, 2022-2030. The key players in the region are spending extensively on the research and development of new products, getting new product approvals, and innovating technologies, driving the market growth.

MARKET INSIGHTS

The North America epilepsy devices market growth assessment includes the evaluation of the United States and Canada. According to the Canadian Epilepsy Alliance, there are around 260,000 epileptics in Canada. 78,000 of them, or 30%, have drug-resistant epilepsy. Canada's healthcare system is funded by public and private sectors, primarily private insurance and out-of-pocket expenses. Spending on public health care in Canada has increased and is anticipated to support market expansion. The population of Canada has increased, and decision-makers in the health system must consider the effects of this growth on the prospective demand for healthcare services in the future.

The greatest demographic segment in recent Canadian history is reaching 65. The consensus is that an aging population would result in higher demands for medical services and a faster pace of increase in health spending. Hospitals in Canada now have more installed and operational computed tomography (CT) and magnetic resonance imaging (MRI) machines. The capacity of medical imaging technologies to identify more anomalies has expanded hospital services.

COMPETITIVE INSIGHTS

Leading companies operating in the market include: Cadwell Industries Inc, Empatica Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 48674

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SOARING OCCURRENCES OF EPILEPSY NORTH AMERICALY
    • 3.1.2. ONSET OF EPILEPSY IN ELDERLY PEOPLE
    • 3.1.3. MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
    • 3.1.4. SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
    • 3.2.2. SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COMFORT & USABILITY
    • 4.7.2. PRODUCT FEATURES
    • 4.7.3. CONFIDENTIALITY
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT TYPE

  • 5.1. CONVENTIONAL DEVICES
  • 5.2. WEARABLE DEVICES
    • 5.2.1. WATCHES
    • 5.2.2. BRACELETS
    • 5.2.3. CAMERA DEVICES
    • 5.2.4. MATTRESS DEVICES
    • 5.2.5. ANTI-SUFFOCATION PILLOWS
    • 5.2.6. OTHER WEARABLE DEVICES
  • 5.3. IMPLANTABLE DEVICES

6. MARKET BY TECHNOLOGY

  • 6.1. VAGUS NERVE STIMULATION
  • 6.2. DEEP BRAIN STIMULATION
    • 6.2.1. MOVEMENT DISORDERS
    • 6.2.2. EPILEPSY
  • 6.3. ACCELEROMETRY
  • 6.4. RESPONSIVE NEUROSTIMULATION

7. MARKET BY DETECTION & PREDICTION DEVICES TYPE

  • 7.1. ELECTROENCEPHALOGRAM
  • 7.2. INTRACRANIAL EEG
  • 7.3. SURFACE ELECTROMYOGRAPHY
  • 7.4. ELECTROCARDIOGRAPHY
  • 7.5. VIDEO DETECTION SYSTEMS
  • 7.6. ELECTRODERMAL ACTIVITY
  • 7.7. IMPLANTED ADVISORY SYSTEMS
  • 7.8. OTHER DETECTION & PREDICTION DEVICE TYPES

8. MARKET BY END-USER

  • 8.1. HOSPITALS & CLINICS
  • 8.2. NEUROLOGY CENTERS
  • 8.3. HOME CARE SETTINGS
  • 8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS
  • 10.2. COMPANY PROFILES
    • 10.2.1. BOSTON SCIENTIFIC CORPORATION
    • 10.2.2. CADWELL INDUSTRIES INC
    • 10.2.3. COMPUMEDICS LIMITED
    • 10.2.4. DRAGERWERK AG & CO KGAA
    • 10.2.5. EMPATICA INC
    • 10.2.6. KONINKLIJKE PHILIPS NV
    • 10.2.7. LIVANOVA PLC
    • 10.2.8. MEDTRONIC PLC
    • 10.2.9. NATUS MEDICAL INCORPORATED
    • 10.2.10. NEUROPACE INC
    • 10.2.11. NEUROSOFT
    • 10.2.12. NIHON KOHDEN CORPORATION
    • 10.2.13. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
Product Code: 48674

LIST OF TABLES

  • TABLE 1: NORTH AMERICA MARKET SNAPSHOT - EPILEPSY DEVICES
  • TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
  • TABLE 3: EXAMPLES OF MOBILE EEG DEVICES
  • TABLE 4: REGULATORY FRAMEWORK
  • TABLE 5: NORTH AMERICA EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: LEADING PLAYERS OPERATING IN NORTH AMERICA EPILEPSY DEVICES MARKET
  • TABLE 20: LIST OF ACQUISITIONS
  • TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 22: LIST OF PARTNERSHIPS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 8: NORTH AMERICA EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021
  • FIGURE 11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
  • FIGURE 19: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021
  • FIGURE 22: NORTH AMERICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 23: NORTH AMERICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021
  • FIGURE 27: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)
  • FIGURE 29: NORTH AMERICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 30: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 31: NORTH AMERICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 32: NORTH AMERICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)
  • FIGURE 33: NORTH AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 34: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE TYPES, 2022-2030 (IN $ MILLION)
  • FIGURE 35: NORTH AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 36: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: NORTH AMERICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 38: NORTH AMERICA EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)
  • FIGURE 39: NORTH AMERICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
  • FIGURE 40: NORTH AMERICA EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 41: UNITED STATES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: CANADA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!